Autoimmune Inflammatory Myopathy after Treatment with Ipilimumab

被引:82
作者
Hunter, Gary [1 ]
Voll, Chris [1 ]
Robinson, Christopher A. [2 ]
机构
[1] Univ Saskatchewan, Dept Neurol, Saskatoon, SK, Canada
[2] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada
关键词
LYMPHOCYTE-ASSOCIATED ANTIGEN-4; TUMOR-REGRESSION; SUSCEPTIBILITY; BLOCKADE; MELANOMA; CTLA4;
D O I
10.1017/S0317167100007939
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
[No abstract available]
引用
收藏
页码:518 / 520
页数:3
相关论文
共 12 条
[1]
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 [J].
Attia, P ;
Phan, GQ ;
Maker, AV ;
Robinson, MR ;
Quezado, MM ;
Yang, JC ;
Sherry, RM ;
Topalian, SL ;
Kammula, US ;
Royal, RE ;
Restifo, NP ;
Haworth, LR ;
Levy, C ;
Mavroukakis, SA ;
Nichol, G ;
Yellin, MJ ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6043-6053
[2]
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 [J].
Beck, Kimberly E. ;
Blansfield, Joseph A. ;
Tran, Khoi Q. ;
Feldman, Andrew L. ;
Hughes, Marybeth S. ;
Royal, Richard E. ;
Kammula, Udai S. ;
Topalian, Suzanne L. ;
Sherry, Richard M. ;
Kleiner, David ;
Quezado, Martha ;
Lowy, Israel ;
Yellin, Michael ;
Rosenberg, Steven A. ;
Yang, James C. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2283-2289
[3]
Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region [J].
Colucci, F ;
Bergman, ML ;
PenhaGoncalves, C ;
Cilio, CM ;
Holmberg, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8670-8674
[4]
The role of the CTLA4 blockade in the treatment of malignant melanoma [J].
Cranmer, Lee D. ;
Hersh, Evan .
CANCER INVESTIGATION, 2007, 25 (07) :613-631
[5]
The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis [J].
Greve, B ;
Vijayakrishnan, L ;
Kubal, A ;
Sobel, RA ;
Peterson, LB ;
Wicker, LS ;
Kuchroo, VK .
JOURNAL OF IMMUNOLOGY, 2004, 173 (01) :157-163
[6]
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: A phase I/II study [J].
Maker, AV ;
Phan, GQ ;
Attia, P ;
Yang, JC ;
Sherry, RM ;
Topalian, SL ;
Kammula, US ;
Royal, RE ;
Haworth, LR ;
Levy, C ;
Kleiner, D ;
Mavroukakis, SA ;
Yellin, M ;
Rosenberg, SA .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (12) :1005-1016
[7]
PHAN GQ, 2003, P AN M AM SOC CLIN, V22, P3424
[8]
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206 [J].
Ribas, A ;
Camacho, LH ;
Lopez-Berestein, G ;
Pavlov, D ;
Bulanhagui, CA ;
Millham, R ;
Comin-Anduix, B ;
Reuben, JM ;
Seja, E ;
Parker, CA ;
Sharma, A ;
Glaspy, JA ;
Gomez-Navarro, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8968-8977
[9]
TCHEKMEDYIAN S, 2002, P AN M AM SOC CLIN, V2, P56
[10]
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease [J].
Ueda, H ;
Howson, JMM ;
Esposito, L ;
Heward, J ;
Snook, H ;
Chamberlain, G ;
Rainbow, DB ;
Hunter, KMD ;
Smith, AN ;
Di Genova, G ;
Herr, MH ;
Dahlman, I ;
Payne, F ;
Smyth, D ;
Lowe, C ;
Twells, RCJ ;
Howlett, S ;
Healy, B ;
Nutland, S ;
Rance, HE ;
Everett, V ;
Smink, LJ ;
Lam, AC ;
Cordell, HJ ;
Walker, NM ;
Bordin, C ;
Hulme, J ;
Motzo, C ;
Cucca, F ;
Hess, JF ;
Metzker, ML ;
Rogers, J ;
Gregory, S ;
Allahabadia, A ;
Nithiyananthan, R ;
Tuomilehto-Wolf, E ;
Tuomilehto, J ;
Bingley, P ;
Gillespie, KM ;
Undlien, DE ;
Ronningen, KS ;
Guja, C ;
Ionescu-Tirgoviste, C ;
Savage, DA ;
Maxwell, AP ;
Carson, DJ ;
Patterson, CC ;
Franklyn, JA ;
Clayton, DG ;
Peterson, LB .
NATURE, 2003, 423 (6939) :506-511